Literature DB >> 9703994

Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway.

J Tamaoki1, E Tagaya, K Isono, A Nagai.   

Abstract

We studied the existence of beta 3-adrenoceptors in canine pulmonary artery smooth muscle under isometric conditions in vitro. A rank order potency of vascular relaxation was isoproterenol > salbutamol > selective beta 3-adrenoceptor agonists, CL 316243 and BRL 37344. A marked desensitization to salbutamol occurred by pretreatment with salbutamol but not with CL 316243. When beta 1-adrenoceptors were blocked, the relaxant responses to salbutamol were competitively antagonized by the beta 2-adrenoceptor antagonist ICI 118551, whereas the response to CL 316243 was not. Cyanopindolol, a non-selective beta-adrenoceptor antagonist, antagonized CL 316243-induced relaxation in a competitive manner with a pA2 of 6.10, and this value was lower than that when salbutamol was used as an agonist (6.69). Intracellular cAMP levels were increased by CL 316243, an effect that was not altered by ICI 118551. Therefore, beta 3-adrenoceptors may be present and functioning in canine pulmonary artery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703994     DOI: 10.1006/bbrc.1998.9047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  The function of alpha- and beta-adrenoceptors of the saphenous artery in caveolin-1 knockout and wild-type mice.

Authors:  S Neidhold; B Eichhorn; M Kasper; U Ravens; A J Kaumann
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

2.  Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.

Authors:  L Brawley; A M Shaw; A MacDonald
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.

Authors:  Véronique Leblais; Fabrice Pourageaud; M Dolores Ivorra; Roger Marthan; Bernard Muller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-13       Impact factor: 3.000

4.  Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.

Authors:  Fabrice Pourageaud; Véronique Leblais; Nadège Bellance; Roger Marthan; Bernard Muller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-26       Impact factor: 3.000

Review 5.  Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system.

Authors:  An L Moens; Ronghua Yang; Vabren L Watts; Lili A Barouch
Journal:  J Mol Cell Cardiol       Date:  2010-02-23       Impact factor: 5.000

6.  The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.

Authors:  C Pott; K Brixius; A Bundkirchen; B Bölck; W Bloch; D Steinritz; U Mehlhorn; R H G Schwinger
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

7.  Evidence against beta 3-adrenoceptors or low affinity state of beta 1-adrenoceptors mediating relaxation in rat isolated aorta.

Authors:  Nataraj Brahmadevara; Angus M Shaw; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

8.  Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.

Authors:  Daniel Scherer; Claudia Kiesecker; Martin Kulzer; Myriam Günth; Eberhard P Scholz; Sven Kathöfer; Dierk Thomas; Martin Maurer; Jörg Kreuzer; Alexander Bauer; Hugo A Katus; Christoph A Karle; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-05-30       Impact factor: 3.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.